Has-miR-612 had an essential function in suppressing Rap1b, a regulator of the MAPK pathway, which is critical in the pathophysiology of PCOS patients with insulin resistance, according to the findings of Hu et al. (40) research. Here, RAP1B is linked to polycystic ovary syndrome.